Search by Drug Name or NDC

    NDC 49502-0345-73 TOBI 300 mg/5mL Details

    TOBI 300 mg/5mL

    TOBI is a ORAL; RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Specialty L.P.. The primary component is TOBRAMYCIN.

    Product Information

    NDC 49502-0345
    Product ID 49502-345_8061b21d-5a04-48c1-b0fe-f769560f4a59
    Associated GPIs 07000070002520
    GCN Sequence Number 037042
    GCN Sequence Number Description tobramycin in 0.225% sod chlor AMPUL-NEB 300 MG/5ML INHALATION
    HIC3 W1F
    HIC3 Description AMINOGLYCOSIDE ANTIBIOTICS
    GCN 61551
    HICL Sequence Number 016926
    HICL Sequence Number Description TOBRAMYCIN IN 0.225 % SODIUM CHLORIDE
    Brand/Generic Brand
    Proprietary Name TOBI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tobramycin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL; RESPIRATORY (INHALATION)
    Active Ingredient Strength 300
    Active Ingredient Units mg/5mL
    Substance Name TOBRAMYCIN
    Labeler Name Mylan Specialty L.P.
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050753
    Listing Certified Through 2024-12-31

    Package

    NDC 49502-0345-73 (49502034573)

    NDC Package Code 49502-345-73
    Billing NDC 49502034573
    Package 56 POUCH in 1 CARTON (49502-345-73) / 4 AMPULE in 1 POUCH (49502-345-99) / 5 mL in 1 AMPULE
    Marketing Start Date 2022-06-23
    NDC Exclude Flag N
    Pricing Information N/A